香港潮商集團有限公司董事(「董事」)會(「董事會」)成員載列如下: 非執行董事 馬蔚華 (主席) 執行董事 MODERN INNOVATIVE DIGITAL TECHNOLOGY COMPANY LIMITED 新質數字科技有限公司 (於百慕達註冊成立之有限公司) (股份代號: 2322) 董事名單及其角色與職能 香港，2024 年 12 月 11 日 鄭菊花 陳志遠 龔煌輝 曹麗 獨立非執行董事 韓正海 (副主席) 季志雄 楊日泉 陳超 董事會轄下設立 3 個委員會。下表提供各董事會成員在該等委員會中所擔任的職 位。 | 董事會轄下委員會 | 提名委員會 | 審核委員會 | 薪酬委員會 | | --- | --- | --- | --- | | 董事 | | | | | 馬蔚華 | | | | | 鄭菊花 | M | | | | 陳志遠 | | | | | 龔煌輝 | | | | | 曹麗 | | | | | 韓正海 | M | M | M | | 季志雄 | M | C | M | | 楊日泉 | C | M | M | | 陳超 | M | M | C | 註: C 有關委員會的主席 M 有關委員會的 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公佈全部或任何 部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 MODERN INNOVATIVE DIGITAL TECHNOLOGY COMPANY LIMITED （於百慕達註冊成立之有限公司） 新質數字科技有限公司 （股份代號：2322） 委任執行董事、獨立非執行董事及副主席 新質數字科技有限公司（「本公司」）董事（「董事」）會（「董事會」）宣佈韓正海先生（「韓 先生」）已獲委任為獨立非執行董事、審核委員會、提名委員會及薪酬委員會各自之 成員及董事會副主席，自2024年12月11日起生效，並進一步宣佈曹麗女士（「曹女士」） 已獲委任為執行董事，自2024年12月11日起生效。 韓正海先生 韓先生，48歲，於投資及管理業務方面擁有豐富的經驗。彼自2021年1月20日起至今 擔任聯交所主板上市公司資本界金控集團有限公司（股份代號：204）（「資本界金 控」）之非執行董事，另自2021年3月11日起擔任資本界金控之董事會主席並自2024年 1月22日起調任為資本界 ...

Financial Performance - The company reported revenue of HKD 35,644,000 for the six months ended September 30, 2024, a decrease of 59.5% compared to HKD 87,998,000 in the same period of 2023[3]. - Gross profit for the same period was HKD 12,188,000, representing a gross margin of approximately 34.2%, compared to HKD 11,438,000 and a margin of 13.0% in 2023[3]. - The company incurred a loss of HKD 30,677,000 for the period, compared to a profit of HKD 4,379,000 in the previous year, indicating a significant decline in profitability[5]. - Total comprehensive loss for the period was HKD 10,309,000, compared to a total comprehensive loss of HKD 34,543,000 in the same period last year[8]. - The company’s financial performance reflects a challenging market environment, with significant declines in revenue across key segments compared to the previous year[27]. - The group reported a pre-tax loss of HKD 23,456 million for the six months ended September 30, 2024, compared to HKD 76,560 million in the same period of 2023[46]. - The company reported a significant decrease in bank interest income, which fell to HKD 65 million from HKD 603 million year-over-year[44]. - The company reported a loss attributable to shareholders of HKD (30,677,000) for the six months ended September 30, 2024, compared to a profit of HKD 4,397,000 in 2023, resulting in a basic loss per share of (0.74) HKD cents versus a profit of 0.11 HKD cents in the previous year[60]. Assets and Liabilities - Non-current assets decreased from HKD 204,185,000 as of March 31, 2024, to HKD 173,155,000 as of September 30, 2024[10]. - Current assets increased from HKD 563,378,000 to HKD 598,508,000 during the same period, indicating a growth of approximately 6.2%[10]. - The company's total assets amounted to HKD 771,663,000 as of September 30, 2024, compared to HKD 767,563,000 as of March 31, 2024[10]. - The company’s cash and bank balances decreased from HKD 129,045,000 to HKD 98,159,000, a decline of approximately 23.9%[10]. - The company’s equity decreased from HKD 723,785,000 to HKD 713,476,000, reflecting a slight decline of 0.2%[13]. - Total liabilities amounted to HKD 58,187 million, with borrowings and factoring at HKD 387 million and lease liabilities at HKD 1,756 million[40]. - The group’s total assets were valued at HKD 893,362 million, reflecting a significant asset base[42]. Revenue Breakdown - Revenue from goods sales was HKD 24,513,000, down from HKD 76,831,000, indicating a decrease of about 68.1% year-over-year[24]. - The trading segment generated revenue of HKD 23,672,000, while the factoring segment contributed HKD 7,975,000, and the financing lease segment added HKD 1,929,000[36]. - The financial services segment reported a loss of HKD 15,475,000, contributing to a total segment loss of HKD 22,593,000 for the six months ended September 30, 2024[36]. - The trading business recorded revenue of approximately HKD 23.7 million and a loss of about HKD 11.7 million for the six months ending September 30, 2024, compared to revenue of approximately HKD 76.8 million and a loss of about HKD 16 million in the same period of 2023[94]. - The financing lease business generated revenue of approximately HKD 1.9 million and profit of about HKD 1.5 million, compared to revenue of approximately HKD 300,000 and profit of about HKD 1.7 million in the previous year[101]. Expenses - The company’s administrative expenses increased to HKD 27,319,000 from HKD 22,180,000, representing a rise of approximately 23.3% year-on-year[4]. - The company incurred total corporate expenses of HKD 31,024,000 during the period, leading to an operating loss of HKD 30,677,000[36]. - Depreciation for property, plant, and equipment was HKD 2,440 million, while depreciation for right-of-use assets was HKD 4,182 million[46]. - The company incurred financing costs of HKD 200 million for lease liabilities, down from HKD 462 million in the previous year[49]. Receivables and Credit Risk - The total receivables from loans and interest increased to HKD 221,302,000 as of September 30, 2024, up from HKD 209,175,000 as of March 31, 2024, with a provision for impairment losses of HKD (46,304,000) compared to HKD (44,738,000) previously[62]. - The company’s trade receivables amounted to HKD 247,156,000 as of September 30, 2024, an increase from HKD 230,675,000 as of March 31, 2024, with total impairment losses of HKD (74,419,000) compared to HKD (59,624,000) previously[68]. - The company reported a significant increase in interest receivables, rising to HKD 40,585,000 as of September 30, 2024, from HKD 32,267,000 as of March 31, 2024[62]. - The company’s impairment provision for receivables increased to HKD 74,419,000 as of September 30, 2024, reflecting a rise in credit risk assessments[77]. - The company continues to maintain strict controls over its receivables, with established procedures to evaluate the credit quality of its clients and determine credit limits[69]. Corporate Governance and Compliance - The company did not apply any new accounting standards or amendments that are not yet effective, and expects no significant impact from future standards[21]. - The company has adopted new accounting standards effective from April 1, 2024, but these did not have a significant impact on the financial statements[20]. - The company’s board of directors is designated as the primary operating decision-maker, assessing performance and allocating resources based on internal reports[29]. - The audit committee consists of three independent non-executive directors, overseeing accounting principles and internal controls[135]. - The group has fully complied with the corporate governance code as of September 30, 2024[130]. Shareholder Information - The company did not recommend an interim dividend for the six months ended September 30, 2024, consistent with the previous year[59]. - The board does not recommend the payment of an interim dividend for the six months ended September 30, 2024[118]. - As of September 30, 2024, the total number of issued shares was 4,120,600,000, with no changes in share capital during the period[118][119]. - There were no purchases, sales, or redemptions of the company's shares by the group or its subsidiaries during the six months ending September 30, 2024[131]. Future Outlook - The group is actively exploring the development of other financial services to increase revenue sources amid a challenging market environment[111]. - The group has engaged an independent appraiser to assist in assessing the impairment of receivables as of September 30, 2024, using an expected credit loss model[114]. - The group has not entered into any foreign exchange hedging instruments and will closely monitor exchange rate fluctuations to mitigate currency risk[118].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公佈全部 或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 MODERN INNOVATIVE DIGITAL TECHNOLOGY COMPANY LIMITED 新質數字科技有限公司 （前稱 Hong Kong ChaoShang Group Limited 香港潮商集團有限公司） (於百慕達註冊成立之有限公司) 本公佈乃新質數字科技有限公司（「本公司」，連同其附屬公司統稱「本集團」） 根據香港聯合交易所有限公司證券上市規則（「上市規則」）第13.09條及證券 及期貨條例（香港法例第571章）第XIVA部項下內幕消息條文（定義見上市規則） 之規定刊發。 本公司董事（「董事」）會（「董事會」）謹此知會本公司股東及投資者，根據 本集團最近期未經審核管理賬目之初步評估，本集團預期於截至2024年9月30日 止六個月錄得大約30,000,000港元之淨虧損，而於2023年同期本集團錄得淨利潤約 4,000,000港元。此轉變主要由於在去年同期內確認持作買賣投資公允值 ...

MODERN INNOVATIVE DIGITAL TECHNOLOGY COMPANY LIMITED 香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公佈全部 或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 董事會會議日期 新質數字科技有限公司（「本公司」）董事會（「董事會」）謹此宣佈，本公司 謹定於2024年11月29日（星期五）舉行董事會會議，藉以（其中包括）考慮及批 准本公司及其附屬公司截至2024年9月30日止六個月未經審核之中期業績及考慮 建議派發中期股息（如有）。 代表董事會 新質數字科技有限公司 主席 馬蔚華先生 新質數字科技有限公司 （前稱 Hong Kong ChaoShang Group Limited 香港潮商集團有限公司） (於百慕達註冊成立之有限公司) (股份代號: 2322) 香港，2024年11月18日 於本公佈日期，董事會成員包括主席及非執行董事馬蔚華先生；執行董事鄭菊花 女士、陳志遠先生及龔煌輝先生；以及獨立非執行董事季志雄先生、楊日泉先生 及陳超先生。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 MODERN INNOVATIVE DIGITAL TECHNOLOGY COMPANY LIMITED 新質數字科技有限公司 （前稱Hong Kong ChaoShang Group Limited香港潮商集團有限公司） （於百慕達註冊成立之有限公司） （股份代號：2322） 更改公司名稱； 更改股份簡稱； 更改公司網站； 及 更改公司標誌 茲提述(i)新質數字科技有限公司（前稱香港潮商集團有限公司）（「本公司」）日期為 2024年8月30日之公告；(ii)本公司日期為2024年9月17日有關（其中包括）更改公司名 稱之通函（「通函」）；及(iii)本公司日期為2024年10月10日有關於2024年10月10日舉行 之股東特別大會投票表決結果之公告。除文義另有所指外，本公告所用詞彙應與通 函所定義者具有相同涵義。 1 更改公司名稱 董事會欣然宣佈，於2024年10月10日舉行之股東特別大會上獲股東批准 ...

1 本公佈僅供參考，並不構成收購、購買或認購本公司任何證券之邀請或要約。 HONG KONG CHAOSHANG GROUP LIMITED 香港潮商集團有限公司 （於百慕達註冊成立之有限公司） （股份代號：2322） 根據一般授權配售新股份失效 茲提述香港潮商集團有限公司（「本公司」）日期為二零二四年十月八日之公佈（「該公 佈」），內容有關配售事項。除另有界定外，本公佈所用詞彙與該公佈所界定者具有 相同涵義。 董事會宣佈，由於配售協議項下之條件未能於二零二四年十月二十九日或之前達 成，配售協議已於二零二四年十月二十九日失效。根據配售協議之條款及條件，訂 約各方於配售協議項下有關配售事項之所有權利、義務及責任將停止及終止，且有 關訂約各方均不得就配售事項向另一方提出任何申索（惟任何先前違約及╱或於有 關終止前配售協議項下可能應計之任何權利或義務除外）。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公佈全部或任何 部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 董事會認為，配售事項失效對本集團現有業務營運及財務 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部 份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 1 HONG KONG CHAOSHANG GROUP LIMITED 香港潮商集團有限公司 （於百慕達註冊成立之有限公司） （股份代號：2322） 截至二零二四年三月三十一日止年度業績公告 香港潮商集團有限公司（「本公司」）董事（「董事」）會（「董事會」）提呈本公司及其附屬 公司（統稱「本集團」）截至二零二四年三月三十一日止年度之已審核綜合業績，連同 上一財政年度之已審核比較數字如下： 綜合損益及其他全面收益表 截至二零二四年三月三十一日止年度 | --- | --- | --- | --- | --- | |------------------------------------|-------|------------|----------------------------------------------|-----------------------------------------| | ...

Financial Performance - Revenue for the six months ended September 30, 2023, was HKD 87,998,000, a decrease of 36.4% compared to HKD 138,359,000 in the same period of 2022[9]. - Gross profit for the same period was HKD 11,438,000, down 45.4% from HKD 20,914,000 year-on-year[9]. - Operating profit for the six months was HKD 3,440,000, a significant improvement from a loss of HKD 15,729,000 in the previous year[10]. - The company reported a total comprehensive loss of HKD 34,543,000, compared to a loss of HKD 87,084,000 in the same period last year[10]. - The company recorded a significant increase in impairment losses on receivables, totaling HKD 15,856,000, compared to HKD 9,590,000 in the previous year[9]. - The company’s earnings per share for the period was HKD 0.11, recovering from a loss of HKD 0.38 per share in the same period last year[10]. - The company reported an operating loss of HKD 29,128 for the period, compared to an operating loss of HKD 32,667 in the same period last year[22][23]. - The total loss for the period was HKD 4,379, with a pre-tax profit of HKD 2,978[22]. - The group reported a profit attributable to shareholders of HKD 4,397,000 for the six months ended September 30, 2023, compared to a loss of HKD 15,632,000 in the same period of 2022[31]. - The group reported a pre-tax loss of HKD 76,560,000 for the six months ended September 30, 2023, compared to a loss of HKD 117,404,000 in the same period last year, indicating a significant improvement[27]. Assets and Liabilities - The total assets as of September 30, 2023, amounted to HKD 893,362,000, a decrease from HKD 916,102,000 as of March 31, 2023[11]. - Total liabilities increased to HKD 94,810,000 as of September 30, 2023, compared to HKD 83,007,000 as of March 31, 2023, representing a growth of 14.5%[12]. - Current liabilities rose to HKD 86,092,000 from HKD 69,352,000, marking a significant increase of 24.1%[12]. - The total equity and liabilities amounted to HKD 893,362,000 as of September 30, 2023, down from HKD 916,102,000, a decrease of 2.5%[12]. - The company’s financial position shows a total equity of HKD 798,552,000 as of September 30, 2023, after accounting for total liabilities[25]. - The group held cash and bank balances of approximately HKD 127,200,000, down from HKD 138,500,000 as of March 31, 2023, while total borrowings decreased to approximately HKD 17,500,000 from HKD 22,400,000[76]. Cash Flow and Investments - Net cash used in operating activities was HKD (2,166,000) for the six months ended September 30, 2023, an improvement from HKD (55,566,000) in the same period last year[14]. - The net cash generated from investing activities was HKD 530,000, a decrease from HKD 7,550,000 in the previous year[14]. - The company reported a cash outflow from financing activities of HKD (5,429,000), slightly higher than HKD (5,095,000) in the prior year[14]. - The company recorded a significant increase in impairment losses on receivables totaling approximately HKD 3.4 million[62]. Business Strategy and Future Outlook - The company plans to focus on market expansion and new product development to improve future performance[8]. - The group is actively seeking business opportunities and may consider restructuring its business segments in response to the changing economic environment in China and Hong Kong[75]. - The group has entered into a non-binding memorandum of understanding with two potential sellers for the acquisition of a target company involved in the promotion and sale of medical devices and health products[75]. Shareholder Information - The group did not recommend an interim dividend for the six months ended September 30, 2023, consistent with the previous year[30]. - The company adopted a new share option scheme effective from September 28, 2023, replacing the previous scheme that expired on September 1, 2023[89]. - The maximum number of shares available for subscription under the share option plan is capped at 10% of the total issued shares as of September 28, 2023, which amounts to 412,060,000 shares[92]. Impairment and Receivables - The company reported a total impairment loss of HKD 84,747,000 for accounts receivable as of September 30, 2023, up from HKD 72,002,000 as of March 31, 2023[50]. - The impairment provision for trade receivables increased to HKD 56,417,000 as of September 30, 2023, compared to HKD 43,571,000 as of March 31, 2023[45]. - The company has adopted a simplified approach to estimate expected credit losses for all receivables in accordance with HKFRS 9[48]. Corporate Governance - The company has fully complied with the corporate governance code as of September 30, 2023[98]. - The audit committee consists of three independent non-executive directors and has reviewed the group's accounting principles and internal controls for the six months ending September 30, 2023[103]. - The board of directors includes two executive directors and three independent non-executive directors as of the report date[104].

[Financial Summary](index=2&type=section&id=Financial%20Summary) [Condensed Consolidated Statement of Profit or Loss and Other Comprehensive Income Summary](index=2&type=section&id=Condensed%20Consolidated%20Statement%20of%20Profit%20or%20Loss%20and%20Other%20Comprehensive%20Income) For the six months ended September 30, 2023, the Group turned profitable with a profit for the period of approximately HKD 4.4 million, compared to a loss of approximately HKD 15.7 million in the prior period, primarily due to a significant increase in fair value gains on financial assets held for trading; however, total revenue decreased by 36.4% year-on-year to approximately HKD 88 million, and gross profit also decreased by 45.3% to approximately HKD 11.4 million Key Profit or Loss Data (For the Six Months Ended September 30) | Metric | 2023 (HKD Thousands) | 2022 (HKD Thousands) | Year-on-Year Change | | :--- | :--- | :--- | :--- | | Revenue | 87,998 | 138,359 | -36.4% | | Gross Profit | 11,438 | 20,914 | -45.3% | | Operating Profit/(Loss) | 3,440 | (15,729) | Turnaround to Profit | | Profit/(Loss) for the Period | 4,379 | (15,652) | Turnaround to Profit | | Profit/(Loss) Attributable to Owners of the Company | 4,397 | (15,632) | Turnaround to Profit | | Basic Earnings/(Loss) Per Share | 0.11 HK cents | (0.38) HK cents | Turnaround to Profit | - The primary driver for the turnaround to profitability was a fair value gain of **HKD 32.84 million** on financial assets held for trading, compared to a loss of **HKD 0.77 million** in the prior period[2](index=2&type=chunk) [Condensed Consolidated Statement of Financial Position Summary](index=5&type=section&id=Condensed%20Consolidated%20Statement%20of%20Financial%20Position) As of September 30, 2023, the Group's total assets were HKD 893 million, a slight decrease from HKD 916 million as of March 31, 2023; total equity decreased from HKD 833 million to HKD 799 million, mainly due to exchange differences from RMB depreciation against HKD, while net current assets remained stable Key Balance Sheet Data | Metric | September 30, 2023 (HKD Thousands) | March 31, 2023 (HKD Thousands) | Change | | :--- | :--- | :--- | :--- | | Total Assets | 893,362 | 916,102 | -2.5% | | Total Liabilities | 94,810 | 83,007 | +14.2% | | Total Equity | 798,552 | 833,095 | -4.1% | | Net Current Assets | 576,243 | 578,059 | -0.3% | [Segment Revenue and Results](index=10&type=section&id=4%20Segment%20Information) The Group's operations are divided into four main segments: trade business revenue significantly declined with expanded losses; lending and factoring business revenue remained stable but profit decreased; finance lease business turned profitable due to impairment reversal; and financial services business revenue decreased but losses narrowed Segment Performance by Business (For the Six Months Ended September 30, 2023) | Business Segment | Segment Revenue (HKD Thousands) | Segment Results (HKD Thousands) | Prior Period Results (HKD Thousands) | | :--- | :--- | :--- | :--- | | Trading | 76,831 | (16,046) | (1,573) | | Lending and Factoring | 8,629 | 3,483 | 5,081 | | Finance Lease | 295 | 1,658 | (3,605) | | Financial Services | 2,243 | (9,492) | (15,331) | | **Total** | **87,998** | **(20,397)** | **(15,428)** | - The expanded loss in the trading business was primarily due to decreased revenue and increased impairment provision for trade receivables[52](index=52&type=chunk) - The finance lease business turned profitable mainly due to the reversal of impairment losses on finance lease receivables[55](index=55&type=chunk) [Management Discussion and Analysis](index=27&type=section&id=Management%20Discussion%20and%20Analysis) [Financial Review](index=27&type=section&id=Financial%20Review) The Group successfully turned profitable during the period, recording a profit of approximately HKD 4.4 million, primarily due to an increase of approximately HKD 24 million in total gains from fair value changes of financial assets held for trading, which effectively offset the negative impacts of decreased gross profit and increased impairment losses on receivables, alongside a reduction in administrative expenses - The turnaround to profitability for the period was primarily influenced by the net effect of four factors[51](index=51&type=chunk): - Total gains from fair value changes and disposal of financial assets held for trading increased by approximately **HKD 24 million** - Gross profit and other income decreased by approximately **HKD 11.4 million** - Total impairment losses on receivables increased by approximately **HKD 3.4 million** - Administrative expenses decreased by approximately **HKD 9.1 million** [Business Review](index=28&type=section&id=Business%20Review) The Group's business segments showed mixed performance during the period: trading business revenue declined with expanded losses due to macroeconomic factors; lending and factoring business remained stable; finance lease business achieved profitability through successful debt recovery; financial services business narrowed losses amid a weak market; and the Group is actively seeking potential acquisition opportunities in the healthcare sector [Trading Business](index=28&type=section&id=Trading%20Business) Trading business revenue decreased by 36% year-on-year to HKD 76.8 million, with losses expanding from HKD 1.6 million to HKD 16 million, primarily due to an unfavorable macroeconomic environment in China impacting demand for non-essential consumer goods like electronics and imported seafood, alongside an impairment loss of approximately HKD 16 million on receivables from a specific customer Trading Business Performance | Metric | Current Period (HKD Thousands) | Prior Period (HKD Thousands) | | :--- | :--- | :--- | | Revenue | 76,800 | 120,000 | | Loss | (16,000) | (1,600) | - The Group made a full impairment provision of approximately **HKD 12.3 million** for receivables from a customer due to unsatisfactory recovery[52](index=52&type=chunk) [Lending and Factoring Business](index=29&type=section&id=Lending%20and%20Factoring%20Business) Lending and factoring business interest income totaled approximately HKD 8.6 million, consistent with the prior period, but profit decreased from HKD 5.1 million to HKD 3.5 million, mainly due to increased administrative expenses; as of period-end, the outstanding loan portfolio had a carrying value of approximately HKD 176 million, and factoring receivables were approximately HKD 18.3 million Lending and Factoring Business Performance | Metric | Current Period (HKD Thousands) | Prior Period (HKD Thousands) | | :--- | :--- | :--- | | Interest Income | 8,600 | 8,400 | | Profit | 3,500 | 5,100 | - As of September 30, 2023, the loan portfolio comprised **23 customers**, with the top five clients accounting for approximately **47%** of the total carrying value of the loan business portfolio[56](index=56&type=chunk) [Finance Lease Business](index=30&type=section&id=Finance%20Lease%20Business) The finance lease business successfully turned profitable, recording a profit of approximately HKD 1.7 million (compared to a loss of HKD 3.6 million in the prior period), primarily due to successful recovery of overdue receivables from certain customers, resulting in an impairment reversal of approximately HKD 2.7 million on finance lease receivables; no new loans were granted during the period due to prudent operations, leading to a decrease in interest income Finance Lease Business Performance | Metric | Current Period (HKD Thousands) | Prior Period (HKD Thousands) | | :--- | :--- | :--- | | Revenue | 300 | 1,100 | | Profit/(Loss) | 1,700 | (3,600) | - The key to the turnaround in performance was the recognition of an impairment reversal of approximately **HKD 2.7 million** on finance lease receivables[55](index=55&type=chunk) [Financial Services Business](index=33&type=section&id=Financial%20Services%20Business) Financial services business losses narrowed from HKD 15.3 million in the prior period to HKD 9.5 million, primarily benefiting from cost control and reduced impairment losses on margin client receivables; however, revenue from brokerage, margin financing, and underwriting businesses decreased to HKD 2.2 million due to a persistently sluggish stock market Financial Services Business Performance | Metric | Current Period (HKD Thousands) | Prior Period (HKD Thousands) | | :--- | :--- | :--- | | Revenue | 2,200 | 8,900 | | Loss | (9,500) | (15,300) | - The Group has initiated legal action regarding the profit guarantee provided by the vendor during the acquisition of this business and has reached a repayment arrangement with the vendor for the second installment of the guaranteed profit compensation[60](index=60&type=chunk) [Potential Business Development and Outlook](index=34&type=section&id=Potential%20Business%20Development) Looking ahead, the Group will actively seek new investment and business opportunities to expand its revenue base; currently, the Group has signed a non-legally binding memorandum of understanding to acquire a company engaged in medical device, nutritional health product promotion, and clinic management system businesses in China - The Group is conducting due diligence for a potential acquisition of a company engaged in healthcare-related businesses in China, and the due diligence period for the related memorandum of understanding has been extended to **May 2024**[61](index=61&type=chunk) [Liquidity, Financial Resources and Liabilities](index=35&type=section&id=Liquidity%2C%20Financial%20Resources%20and%20Liabilities) The Group maintains a sound financial position, primarily relying on internal resources to meet working capital needs; as of period-end, the debt-to-equity ratio decreased from 2.69% to 2.18%, and the current ratio was 7.69 times, indicating strong solvency and ample liquidity Liquidity and Financial Resources Metrics | Metric | September 30, 2023 | March 31, 2023 | | :--- | :--- | :--- | | Cash and Bank Balances | HKD 127 million | HKD 139 million | | Debt-to-Equity Ratio | 2.18% | 2.69% | | Current Ratio | 7.69 | 9.33 | [Securities Investment Portfolio](index=36&type=section&id=Securities%20Investments%20Held) As of September 30, 2023, the Group held two Hong Kong-listed securities investments with a total market value of approximately HKD 40.3 million, with the investment in Ying Fai Enterprise Holdings recording a fair value gain of approximately HKD 33.1 million during the period Details of Securities Held for Trading | Company Name | Stock Code | Shareholding Percentage | Acquisition Cost (HKD Thousands) | Fair Value at Period-End (HKD Thousands) | Fair Value Change Gain for the Period (HKD Thousands) | | :--- | :--- | :--- | :--- | :--- | :--- | | Ying Fai Enterprise Holdings Limited | 2195 | 6.31% | 8,367 | 37,830 | 33,101 | | Vicon Holdings Limited | 3878 | 4.6% | 3,915 | 2,451 | (262) | [Other Significant Matters](index=18&type=section&id=Other%20Significant%20Matters) [Interim Dividend](index=18&type=section&id=Interim%20Dividend) The Board does not recommend the payment of an interim dividend for the six months ended September 30, 2023 - The Board does not recommend the payment of an interim dividend for the six months ended September 30, 2023 (prior period: nil)[33](index=33&type=chunk)[64](index=64&type=chunk) [Corporate Governance](index=37&type=section&id=Corporate%20Governance) The Company fully complied with the Listing Rules' Corporate Governance Code during the reporting period; the Audit Committee reviewed the unaudited condensed consolidated financial statements for the period, and no shares of the Company were purchased, sold, or redeemed by the Company or any of its subsidiaries during the period - The Company fully complied with all provisions of the Corporate Governance Code for the six months ended September 30, 2023[70](index=70&type=chunk) - The Audit Committee, comprising three independent non-executive directors, reviewed the Group's accounting principles, internal controls, and financial reporting matters, including these interim financial statements, with management[74](index=74&type=chunk) - During the period, neither the Company nor any of its subsidiaries purchased, sold, or redeemed any shares of the Company[70](index=70&type=chunk)